Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO Detail
02587 健康之路
HEALTHYWAY INC
Register Close2024/12/23    IPO Closing in 3 Days
Listing Date2024/12/30
COMPANY PROFILE

HealthyWay Inc. operate a digital health and medical service platform in China. The Group is the fourth largest digital health and medical service platform in terms of the number of registered individual users on its platform as of December 31, 2023, according to Frost & Sullivan. The Group is also the fifth largest digital health and medical service platform in terms of revenue in 2023 with market share below 5%.

--

The Group develops its services to enable key industry stakeholders in the digital health and wellness industry in China. These industry stakeholders primarily include individual users; corporations and institutions such as pharmaceutical companies, hospitals, insurance companies and local health authorities; and physicians.

--

For individual users, the Group mainly provides them with health and medical services through its platform, so that they are enabled to manage their health and wellness more easily. For corporations and institutions, the Group mainly provides corporate and digital marketing services to enhance their operational efficiency and support their business growth.

BASIC INFORMATION
MarketHong Kong (Main Board)
Business NatureHealth Care
Major Business AreaChina
Board Lot500
GLOBAL OFFERING
No. of Offer Shares25.00M shares
No. of International Offer Shares22.50M shares
No. of HK Offer Shares2.50M shares
Offer Price$7.80 - $8.80
Stock Code2587
Sponsor(s)CCB International Capital Limited
Underwriter(s)CCB International Capital Limited, Shenwan Hongyuan Securities (H.K.) Limited, BOCI Asia Limited, Livermore Holdings Limited, Fosun International Securities Limited, Zhongtai International Securities Limited, China Everbright Securities (HK) Limited, Ruibang Securities Limited, Sinolink Securities (Hong Kong) Company Limited, Victory Securities Company Limited, Futu Securities International (Hong Kong) Limited, Patrons Securities Limited
TIME TABLE
Application PeriodDec 18 (Wed) - noon, Dec 23 (Mon)
Price Determination DateDec 24 (Tue)
Result Announcement DateOn or before Dec 27 (Fri)
Result Announcement DateOn or before Dec 27 (Fri)
Result Announcement DateOn or before Dec 30 (Mon)
Dealings in Shares commence onDec 30, 2024. (Mon)
Reallocation of Shares Offered
Times of HK Offer Shares Subscription15X - 50X50X - 100XOver 100X
% of total shares reallocated to HK Offer30%40%50%
Sales Statistics (HKD)
Offer Price$7.80 - $8.80
Capitalization6.85B - 7.72B
NAV / share ($)$0.21 - $0.23 (Unaudited pro forma adj NAV / share)
Use Of Proceeds
Assuming the offer price being at HKD 8.3, the net proceeds raised would be HKD 121.20M, of which
60.5% : For health and medical services and corporate and digital marketing services
21% : Strategic investments or acquisitions
14.5% : Research and development
4% : Working capital
Related Document
Remark: The above information is referenced from the prospectus.
  All data is calculated from the non- exercise rights(if applicable).
IPO Calculator
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --
Offer Price︰--
Currency :
Listing Price :
Board Lot :
Admission Fee*
:
Subscribing Lot :
Subscribing Fee :

Subscribing Amount :
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.